The WA company behind an imaging device which can reduce the number of repeat surgeries for breast cancer patients has received $27 million in a private funding round to support its push to US FDA approval.
Perth companies OncoRes Medical and PhosEnergy are among the latest recipients of federal government research grants, with OncoRes also looking to close a private capital raising.
A device to predict kidney disease and a diagnostic imaging tool for cancer surgery are among the innovations awarded a share of $450,000 for commercialisation.
A WA-developed imaging device that can reduce the number of repeat surgeries for breast cancer patients has received a major accreditation from the US Food and Drug Administration.
The pharmaceutical and medical technology sector in WA has launched an industry association, more than one year after the state government promised its own growth plan for the industry.
OncoRes Medical has been awarded $1 million in federal funding to develop technology that can reduce the need for repeat operations in breast cancer patients.
SPECIAL REPORT: Despite WA's history of innovative medical research, the state's medtech sector continues to grapple with outsider perceptions and its own commercial direction.
The state government has appointed an industry reference group to develop a growth plan for WA's health and medical life sciences sector to be chaired by Peter Klinken.
Perth company OncoRes Medical is in the midst of an unusual fundraising campaign, the success of which is tied to the number of clicks on one of its videos on social media (click through to see the video).
Kimberley Pharmacy Services director and remote area pharmacist Hannah Mann has received the highest honour at this year's Business News 40under40 Awards, being named First Amongst Equals in a diverse pool of young business and community leaders.
A Nedlands-based tech startup that is aiming to raise $15 million next year has been chosen as joint winner in global finals for international startup competition Pitch@Palace at St James's Palace, London.
Newly established Perth company OncoRes Medical has secured up to $6 million of funding to commercialise a surgical tool developed by researchers at the Harry Perkins Institute of Medical Research and the University of Western Australia.
